版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、標(biāo)題:GPCR化合物庫- Medchemexpress (MCE)品牌: Medchemexpress (MCE)保存條件: -20供應(yīng)商: MCE中國數(shù)量: 大量保質(zhì)期: 2年規(guī)格:提供組合定制服務(wù)(現(xiàn)貨供應(yīng))供貨地址:美國 MedChemExpress (MCE)專注于各種抑制劑、調(diào)節(jié)劑、API、天然產(chǎn)物及化合物庫,總部位于美國新澤西。MCE經(jīng)過十年努力已成為全球生物活性小分子領(lǐng)域的一流供應(yīng)商。MedChemExpress(MCE)產(chǎn)品涵蓋近20個熱門研究領(lǐng)域,1000多個細分靶點,超過3000個現(xiàn)貨抑制劑、拮抗劑和激動劑。相關(guān)的應(yīng)用成果已發(fā)表于Nat
2、ure、Cell等國際知名雜志,在全球20余個國家地區(qū)設(shè)有代理機構(gòu)。上海皓元生物醫(yī)藥科技有限公司(MCE 中國) 是MedChemExpress (MCE) 亞洲總代理。 貨號:HY-L006 A unique collection of 190 small molecules targeting G protein coupled receptors used in GPCR screening for various research and drug development projects. All of the small molecules in the GPCR li
3、brary are well characterized with biological and pharmaceutical activity. A powerful tool for discovering GPCR-based drugs that are the richest signal receptor targets for drug discovery. Targets such as 5-HT Receptor, Dopamine Receptor, Opioid Receptor, Adrenergic Receptors, Cannabinoid Receptor, m
4、GluR, and ETA-receptor etc. Structurally diverse, medicinally active, and cell permeable. Rich documentation with structure, IC50, and brief introduction. NMR and HPLC validated to ensure the highest purity.Formulation: A collection of 190 active molecules supplied as pre-dissolved DMSO solutio
5、nsContainer: 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D BarcodeStability: 3 months -20°C in DMSO, 6 months -80°C in DMSOShipping: Blue icePackaging: Inert gasPlate layout: HY-EmptyAlosetron (Hydrochloride)AripiprazoleBRL 54443Clozapin
6、e N-oxideCP-809101 (hydrochloride)bEmptyOndansetron (hydrochloride dihydrate)Palonosetron (Hydrochloride)QuetiapineSB 271046 (Hydrochloride)SB-269970 (hydrochloride)cEmptyWAY-100635 (maleate salt)AdoprazineCapadenosonIstradefyllineLUF6000dEmptyHOKU-81ICI 118,551 (hydrochloride)IndacaterolIsoprenalin
7、e (hydrochloride)Ivabradine (hydrochloride)eEmptyTapentadol (hydrochloride)Angiotensin II humanAVE 0991AzilsartanAzilsartan medoxomil (monopotassium)fEmptyAM630JWH 073OtenabantRimonabant (Hydrochloride)TaranabantgEmptyINCB3344MK-0812MK-0974MK-3207 (Hydrochloride)OlcegepanthEmptySCH 527123SCH 546738S
8、CH 563705SRT3190WZ811789101112aLorcaserin (Hydrochloride)LoxapineLu AE58054 (Hydrochloride)LY 344864OlanzapineEmptybSB-742457SetiptilineTianeptineTropisetronVortioxetineEmptycPreladenantTozadenantAdipoRonCarvedilolFormoterol (Fumarate)EmptydMirabegronSalmeterol xinafoateSilodosinVilanterolAsenapineE
9、mptyeEprosartan (mesylate)OlmesartanOlmesartan medoxomilPD 123319 (ditrifluoroacetate)TelmisartanEmptyfWIN 55,212-2 (Mesylate)Calcium-Sensing Receptor Antagonists ICinacalcetNPS-2143NPS-2143 (hydrochloride)EmptygAMD-070 (hydrochloride)AMG 487NBI-74330PlerixaforReparixinEmptyhAMD 3465 (hexahydrobromi
10、de)Lurasidone (Hydrochloride)AmisulprideArmodafinilBrexpiprazoleEmptyPlate layout: HY-EmptyCariprazineHaloperidolPaliperidonerac-Rotigotine (Hydrochloride)RotigotinebEmptyBosentanMacitentanSitaxsentan (sodium)ZibotentanAnamorelincEmptyMK 0893BudesonideCortisone (acetate)DexamethasoneGlu
11、cocorticoid receptor agonistdEmptyGPR120 modulator 2GPR40 Activator 1GW-1100GW9508TAK-875eEmptyEbrotidineLoratadineMetiamidePitolisant (hydrochloride)ZaltidinefEmptyKi16425(R)-(+)-Tolterodine(R)-5-Hydroxymethyl TolterodineAclidinium (Bromide)CevimelinegEmptyUmeclidinium (bromide)VU0152100Xanomeline
12、(oxalate)CTEPDipragluranthEmptyVU 0357121GSK962040AprepitantNKP608SB-222200789101112aST-836 (hydrochloride)Ziprasidone (hydrochloride monohydrate)AmbrisentanAtrasentan (hydrochloride)AvosentanEmptybIbutamoren (Mesylate)Exendin-4glucagon receptor antagonists-1glucagon receptor antagonists-2glucagon r
13、eceptor antagonists-3EmptycTGR5 Receptor AgonistMK-6892GSK1292263MBX-2982GPR120 modulator 1EmptydTUG-770Bavisant (dihydrochloride hydrate)Bepotastine (Beslilate)Ciproxifan (maleate)Clemizole (hydrochloride)EmptyeFenspiride (Hydrochloride)Montelukast (sodium)AM095AM966Fingolimod (hydrochloride)Emptyf
14、DarifenacinDiphenmanil (methylsulfate)Solifenacin (hydrochloride)Tarafenacin (D-tartrate)Tiotropium (Bromide)EmptygLY341495LY404039mGlu2 agonistMPEP (Hydrochloride)MTEP (hydrochloride)EmptyhTalnetantML314ADL-5859Alvimopan (dihydrate)BAN ORL 24EmptyPlate layout: HY-EmptyCebranopadolJDTic
15、 (dihydrochloride)Meptazinol (hydrochloride)Methylnaltrexone (Bromide)Naloxone (hydrochloride)bEmptySuvorexantTCS 1102MRS 2578PrasugrelTicagrelorcEmptyProstaglandin E1SalirasibCCG-63802CCG-63808Siramesine (hydrochloride)dEmptyEmptyEmptyEmptyEmptyEmptyeEmptyEmptyEmptyEmptyEmptyEmptyfEmptyEmptyEmptyEmptyEmptyEmptygEmptyEmptyEmptyEmptyEmptyEmptyhEmptyEmptyEmptyEmptyEmptyEmpty789101112aNaltrexoneAlmorexant (hydrochloride)SB-334867 (free base)SB-408124SB-674042EmptybAH 6809LaropiprantMK-2894OC000459ONO-AE3-208Empty
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度個人貴金屬交易融資合同范本民間版4篇
- 二零二五年度網(wǎng)絡(luò)安全股份公司成立股東數(shù)據(jù)安全協(xié)議3篇
- 2025版危險品運輸駕駛員勞動合同標(biāo)準(zhǔn)范本3篇
- 2025年高標(biāo)準(zhǔn)圍墻建設(shè)及維護服務(wù)合同細則3篇
- 二零二五年酒類企業(yè)產(chǎn)品追溯與防偽技術(shù)合作合同3篇
- 2024破樁勞務(wù)分包合同
- 2025年食堂承包合同補充協(xié)議強調(diào)食品安全與衛(wèi)生規(guī)范3篇
- 與物業(yè)公司合同范本(2024版)
- 鄭州科技學(xué)院《藝術(shù)考察與創(chuàng)新設(shè)計》2023-2024學(xué)年第一學(xué)期期末試卷
- 2025年度戶外景觀門窗工程分包合同范本8篇
- 南通市2025屆高三第一次調(diào)研測試(一模)地理試卷(含答案 )
- 2025年上海市閔行區(qū)中考數(shù)學(xué)一模試卷
- IF鋼物理冶金原理與關(guān)鍵工藝技術(shù)1
- 銷售提成對賭協(xié)議書范本 3篇
- 勞務(wù)派遣招標(biāo)文件范本
- 信息安全意識培訓(xùn)課件
- Python試題庫(附參考答案)
- 碳排放管理員 (碳排放核查員) 理論知識考核要素細目表三級
- 2024年河北省中考數(shù)學(xué)試題(含答案解析)
- 小學(xué)二年級數(shù)學(xué)口算練習(xí)題1000道
- 納布啡在產(chǎn)科及分娩鎮(zhèn)痛的應(yīng)用
評論
0/150
提交評論